Risdiplam is an SMN2 pre-mRNA splicing modifier designed ... It's one of three drugs approved for SMA, the others being nusinersen (Spinraza) and onasemnogene abeparvovec (Zolgensma).
who had one or two copies of the SMN2 backup gene, or two copies of the SMN2 backup gene, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback